Economic Burden of Type 2 Diabetes Mellitus among Patients in the Rural Field Practice Area of a Medical College in Davangere - A Cross Sectional Study

Ayesha S Nawaz, Aswin Kumar, Kiran Shankar, Sindhu P

Abstract


Background: Diabetes is rapidly emerging as a major health care problem, even in rural India. The earlier occurrence, delayed diagnosis and improper care leads to high complication rates, greater productivity loss and consequently higher costs. As the epidemiological burden of diabetes increases, the economic burden is expected to rise and the economically disadvantaged will be affected the most.

Objectives: To assess the economic burden of diabetes among type 2 diabetic patients and to explore the factors associated with the economic burden of diabetes.

Materials and Methods: Community based cross sectional study was carried out in rural field practice area of a medical college in Davangere for a period of six months during 2016-17 among 112 patients with type 2 diabetes mellitus. Information was collected using pretested predesigned questionnaire on socio-demographic details, health services utilization, expenditure incurred on diabetes care (both direct and indirect costs) in the past six months.

Results: The direct cost accounted for 94.2% of the total cost of treatment, of which hospitalization for diabetes related complications and medications were major components. Source of health care significantly influenced the direct cost. About 8.9% of study subjects skipped medications at least once due to lack of money.

Conclusions: Direct cost in the management of diabetes is major contributor to the expenditure. Availability of affordable essential quality diabetic medications and strengthening of public healthcare is crucial in reduction of these direct costs involved in diabetic management.


Keywords


Direct cost, Economic burden, Indirect cost, Type 2 diabetes mellitus

Full Text:

PDF

References


World Health Organization. Global report on diabetes.

WHO, France. 2016.

Mathers CD, Loncar D. Projections of global mortality

and burden of disease from 2002 to 2030. PLoS Med

; 3(11): e442.

Department of noncommunicable diseases and

environmental health. Diabetes fact sheet 2015. Cited

June 12. Available from: http://www.searo.who.

int/myanmar/mediacentre/factsheet_ncd(diabetes).

pdf?ua=1.

Arogya world Factsheet: diabetes in India. Cited 2018

June 12. Available from: http://www.arogyaworld.

org/wp-content/uploads/2010/10/ArogyaWorld_

IndiaDiabetes_FactSheets_CGI2013_web.pdf.

Rayappa PH, Raju KNM, Kapur A, et al. Economic cost

of diabetes care the Bangalore urban district diabetes

study. Int J Diab Dev Countries 1999; 19: 87-97.

International Diabetes Federation. IDF Diabetes Atlas.

Eighth Edition, 2017.

Thakur A, Ray TK, Goel MK. Expenditure pattern on

diabetes care: A Community based longitudinal study

in resettlement colony of East Delhi. Indian J Comm

Health 2017; 29(2): 209-12.

Kapur A. Economic analysis of diabetes care. Indian J

Med Res 2007; 125: 473-82.

Grover S, Avasthi A, Bhansali A, et al. Cost of ambulatory

care of diabetes mellitus: a study from north India.

Postgrad Med J 2005; 81: 391-5.

Loganathan ACV, John KR. Economic burden of diabetes

in people living with the disease; a field study. Journal

of Diabetology 2013; 4(3): 5.

Ramachandran A, Ramachandran S, Snehalatha C, et

al. Increasing expenditure on health care incurred by

diabetic subjects in developing country. Diabetes Care

; 30: 252-6.

Bommer C, Heesemann E, Sagalova V, et al. The

global economic burden of diabetes in adults aged

-79 years: a cost-of-illness study. Lancet Diabetes

Endocrinol 2017; 5: 423-30.

Ramachandran A. Socio-economic burden of diabetes

in India. Supplement of JAPI 2007; 55: 9-12.

Akari S, Mateti UV, Kunduru BR. Health-care cost of

diabetes in South India: a cost of illness study. J Res

Pharm Pract 2013; 2(3): 114-7.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 International Journal of Preventive, Curative & Community Medicine (ISSN: 2454-325X)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.